Great interest been have develop to discover new excipients to solve problem that faced us during formulation like incompatibility and compressibility that lead to slow down manufacturing processes. Linseed mucilage has properties that suggested it as useful additives and binding agent like inertness, nontoxic and viscosity. The purpose of the present study was to extract and evaluate linseed mucilage as binding agent in prednisolone tablets.
Introduction
Solid dosage prepared with aid of suitable additives dependent on intended use and method of manufacture. Examples of excipients that can be used fillers, binders, disintegrants and lubricants¹. There are many types of binders from natural source or synthetics. Added to drug mixture to insure granules and tablets can be formed with the required strength.They can be added in the form of powder in dry granulation method or in liquid in wet granulation method it included in formulation in low concentrations typically 2%-10% by weight Mucilage is most commonly used excipient in pharmaceutical preparations has high molecular weight, sticky and gummy substance; they are esters of sulphoric acid which is a polysacharide 7 .There are two methods of mucilage isolations hot and cold, in cold method seed soaked in distilled water for 5
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Mucilage have a variety of application as tablet binder, disintegrant, emulsifiers, suspending agent, gelling agent, stabilizing agent, thickening agent, film forming agent, and as sustain agent in matrix tablet 10 .
Linseed
Mucilage Prednisolone is glucocorticoids act by inhibiting leukocyte infiltration at the site of inflammation, used for the treatment of adrenocortical insufficiency and rheumatoid arthritis 13 .
The development of new tablet binder to achieve the optimum quality of the tablet, the objective of this study starting by extracting linseed mucilage, prepare the tablet using three different concentrations of the mucilage and then tablet evaluations.
Materials and Methods
Materials are illustrated in table 1. 
Extraction of linseed mucilage
The linseeds were washed with water to remove dirt's and debris, seeds were powdered and soaked in water for six hour, boiled for forty five min and left stand for one hour to allow complete release of mucilage into water, the mucilage was extracted using multilayer muslin cloth bag to remove the marc from the solution, acetone (in the volumes of three times to the volume of filtrate) was added to precipitate the mucilage, the mucilage was separated, dried, in an oven at 40°c collected, sieved and stored 14 .
Physiochemical properties of mucilage
Physiochemical properties such as swelling index, pH, bulk density, tapped density, Hausners ratio, compressibility index and angle of repose were determined according to official procedures 12 .
Pre-compression parameters
The powder blend was evaluated by determination of bulk density, tapped density, angle of repose, compressibility index and Hausner ratio according to the BP guidelines.
Preparation of the tablet
The tablets were prepared by wet granulation method, prednisolone, linseed mucilage and MCC were mixed together and the mixture was passed through mech(no.60), granulation was done using a sufficient amount of distilled water the wet mass passed through mesh (no.35) and mixed with magnesium state and talc, tablets were compressed using single rotary tablet press (lab press-1/Shakti pharmatech Pvt Ltd).
Three different formulas having different concentrations of linseed mucilage (3%, 5% and 7% w/w) were developed and total tablet weight 200mg.the composition of the designed formulations were showed in Table 2 . 
Evaluation of the tablets
All tablets were evaluated for following different parameters which include 15 
General appearance
Five tablets from different batches were randomly selected and organoleptic properties such as color, odor and shape were evaluated. Hardness indicate the ability of a tablet to withstand shocks will handling, the hardness of the tablets were determined using Erweka hardness tester, it was expressed in kg/cm 2 , ten tablets were randomly picked from each formuland hardness of the tables wasdetermined.
Hardness test
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Weight variation test
Randomly twenty tablets were selected after compression weighed individually and average was determined.
Friability test
Friability of the tablets was determined using Roche Friabilator.
This device subjects the tablets to the combined effect of abrasion and shock in a plastic chamber revolving at 25 rpm and dropping the tablets at a height of 6 inches in each revolution. Pre weighed sample of ten tablets was placed in the friabilator for 4 minutes. Tablets were de dusted using a soft wiper and re weighed.
The friability (f) is given by the formula:
Where Wo is weight of the tablets before the test and W is the weight of the tablet after the test.
Disintegration test
The disintegration test was performed in a BP Basket rack assembly using 1000ml pH 6.8 phosphate buffer maintained at 37±0.5°C.
Swelling index
The extent of swelling was measured in terms of % weight gain by the tablet. The swelling behavior of formulations F1, F2 and F3 were studied. One tablet from each formulation was kept in a Petri dish containing pH 6.8 phosphate buffer at the end of 2 h, 4 h and 6 h, kept on tissue paper and weighed and the process was continued till the end of 24 h, the percent weight gain by the tablet was calculated by formula:
Where; S.I = swelling index, Wt = weight of tablet at time (t), Wo = weight of tablet at time t = 0
In vitro drug release studies
Release of Prednisolne from the formulated tablets was studied in phosphate buffer of pH 6.8 and acidic buffer 1.2 (900ml) using a United State Pharmacopoeia (USP) 6-station Dissolution Rate Test Apparatus with a rotating paddle stirrer at 50 rpm and 37° ± 0.5°C as prescribed for Prednisolone tablets in USP 14 . Prednisolone analyzed by UV spectrophotometer at 247 nm 15 .
Results and Discussion

Extraction of Linseed mucilage
The average yield of dried mucilage obtained from linseeds was 31% w/w, the mucilage obtained was yellowish brown color powder and mucilage identified by giving positive results to Rutheinium test 16 .
Physiochemical properties of the mucilage
The mucilage studied for its swelling behavior in distilled water in buffer in pH 6.8 and generally the swelling index calculated indicated that the mucilage can act well as binding agent 17 .
Compressibility index, Hausner ratio and Angle of ripose showed good flowability that enhances the quality of manufacturing processes 2 (Table 3) . 
Pre-compression parameters
Prednisolone granules were prepared by wet granulation method using distilled water in sufficient quantity and evaluated for it physical characterization before compression. The Angle of repose results showed excellent flow, the compressibility index was found to be in the range of 10.3% to 13.8% and the
Hausner ratio in the range of 1.1 to 1.16 indicating very good flowability 2 (Table 4) . 
Evaluation of the tablets
General appearance
Prednisolone tablets were very pale white in color, smooth, and flat shaped in appearance.
Hardness test
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Tablet hardness increased follows mucilage percent increasing in the formulation. Table 5 and figure 1 shows the results. 
Weight variation
Average weight was determined and stander deviations and tablet mean calculated, none of the tablets deviated from the average weight by more than ±5 according to USP (Table 6 ).
Friability test
Test of friability was carried in ten tablets from each formula, the result can help to predict that those tablets can withstand other manufacturing process need to be conducted 1 (Table 7) .
Disintegration test
The tablet disintegrated toke time to disintegrate but it reserved it shape as granules not turn into fine powder (Table 8 ). 
Swelling index
The swelling behavior of all formulation was studied showed the swelling characteristics of linseed mucilage containing tablets; the swelling index was calculated with respect to time, as time increases, the swelling index was increased (Fig 2) .
Fig 2: Tablet swelling index
Dissolution test result
Dissolution test results of the tablet formulated in acidic media pH1.2 showed percent of release 14.49% ,17.88% and 20.33%
for f1, f2 1nd f3 respectively in dissolution time two hours.
Table8 showed the percentage of release.
The dissolution behavior of the tablet in pH 6.8 presented in table 9 and Figure 3 Further studies must be conducted for different concentrations of the linseed mucilage in different pH medium and carry stability study.
Conclusions
The tablets formulations showed acceptable general appearance, formula mucilage 7% showed the best flowability of granules, hardness and friability when compared with formulas 3% and 5%.
In weight variation test indicated that the type and concentration of mucilage used were not significant. Increasing the percent of the mucilage in the formula lead to increase the hardness of the tablet.The tablets swelling index increased when mucilage concentrations were increased. Thanks and praise be to Allah to complete this work and prayers and peace be upon the prophet Muhammad peace be upon him.
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